|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMSP0505AC05
|
|
Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(4)-HexNAc-Cer 42:1;O2
|
C74H136N2O28
|
1500.927970
|
|
LMSP0505AC06
|
|
Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(4)-HexNAc-Cer 44:1;O2
|
C76H140N2O28
|
1528.959270
|
|
LMSP0505AC07
|
|
Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(4)-HexNAc-Cer 42:2;O2
|
C74H134N2O28
|
1498.912320
|
|
LMSP0505AC08
|
|
Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(4)-HexNAc-Cer 44:2;O2
|
C76H138N2O28
|
1526.943620
|
|
LMSP0505AD01
|
type II antigen(d18:1/16:0)
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(3)-HexNAc-Fuc-Cer 34:1;O2
|
C66H120N2O27
|
1372.807855
|
|
LMSP0505AD02
|
type II antigen(d18:1/18:0)
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(3)-HexNAc-Fuc-Cer 36:1;O2
|
C68H124N2O27
|
1400.839155
|
|
LMSP0505AD03
|
type II antigen(d18:1/20:0)
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(3)-HexNAc-Fuc-Cer 38:1;O2
|
C70H128N2O27
|
1428.870455
|
|
LMSP0505AD04
|
type II antigen(d18:1/22:0)
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(3)-HexNAc-Fuc-Cer 40:1;O2
|
C72H132N2O27
|
1456.901755
|
|
LMSP0505AD05
|
type II antigen(d18:1/24:0)
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(3)-HexNAc-Fuc-Cer 42:1;O2
|
C74H136N2O27
|
1484.933055
|
|
LMSP0505AD06
|
type II antigen(d18:1/26:0)
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(3)-HexNAc-Fuc-Cer 44:1;O2
|
C76H140N2O27
|
1512.964355
|
|
LMSP0505AD07
|
type II antigen(d18:1/24:1(15Z))
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(3)-HexNAc-Fuc-Cer 42:2;O2
|
C74H134N2O27
|
1482.917405
|
|
LMSP0505AD08
|
type II antigen(d18:1/26:1(17Z))
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(3)-HexNAc-Fuc-Cer 44:2;O2
|
C76H138N2O27
|
1510.948705
|
|
LMSP0505AE01
|
type II B antigen(d18:1/16:0)
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(4)-HexNAc-Fuc-Cer 34:1;O2
|
C72H130N2O32
|
1534.860680
|
|
LMSP0505AE02
|
type II B antigen(d18:1/18:0)
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(4)-HexNAc-Fuc-Cer 36:1;O2
|
C74H134N2O32
|
1562.891980
|
|
LMSP0505AE03
|
type II B antigen(d18:1/20:0)
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(4)-HexNAc-Fuc-Cer 38:1;O2
|
C76H138N2O32
|
1590.923280
|
|
LMSP0505AE04
|
type II B antigen(d18:1/22:0)
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(4)-HexNAc-Fuc-Cer 40:1;O2
|
C78H142N2O32
|
1618.954580
|
|
LMSP0505AE05
|
type II B antigen(d18:1/24:0)
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(4)-HexNAc-Fuc-Cer 42:1;O2
|
C80H146N2O32
|
1646.985880
|
|
LMSP0505AE06
|
type II B antigen(d18:1/26:0)
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(4)-HexNAc-Fuc-Cer 44:1;O2
|
C82H150N2O32
|
1675.017180
|
|
LMSP0505AE07
|
type II B antigen(d18:1/24:1(15Z))
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(4)-HexNAc-Fuc-Cer 42:2;O2
|
C80H144N2O32
|
1644.970230
|
|
LMSP0505AE08
|
type II B antigen(d18:1/26:1(17Z))
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(4)-HexNAc-Fuc-Cer 44:2;O2
|
C82H148N2O32
|
1673.001530
|
|
LMSP0505AF01
|
type II A antigen(d18:1/16:0)
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(3)-HexNAc(2)-Fuc-Cer 34:1;O2
|
C74H133N3O32
|
1575.887229
|
|
LMSP0505AF02
|
type II A antigen(d18:1/18:0)
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(3)-HexNAc(2)-Fuc-Cer 36:1;O2
|
C76H137N3O32
|
1603.918529
|
|
LMSP0505AF03
|
type II A antigen(d18:1/20:0)
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(3)-HexNAc(2)-Fuc-Cer 38:1;O2
|
C78H141N3O32
|
1631.949829
|
|
LMSP0505AF04
|
type II A antigen(d18:1/22:0)
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(3)-HexNAc(2)-Fuc-Cer 40:1;O2
|
C80H145N3O32
|
1659.981129
|
|
LMSP0505AF05
|
type II A antigen(d18:1/24:0)
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(3)-HexNAc(2)-Fuc-Cer 42:1;O2
|
C82H149N3O32
|
1688.012429
|
|
LMSP0505AF06
|
type II A antigen(d18:1/26:0)
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(3)-HexNAc(2)-Fuc-Cer 44:1;O2
|
C84H153N3O32
|
1716.043729
|
|
LMSP0505AF07
|
type II A antigen(d18:1/24:1(15Z))
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(3)-HexNAc(2)-Fuc-Cer 42:2;O2
|
C82H147N3O32
|
1685.996779
|
|
LMSP0505AF08
|
type II A antigen(d18:1/26:1(17Z))
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(3)-HexNAc(2)-Fuc-Cer 44:2;O2
|
C84H151N3O32
|
1714.028079
|
|
LMSP0505AG01
|
Ley-6(d18:1/16:0)
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(3)-HexNAc-Fuc(2)-Cer 34:1;O2
|
C72H130N2O31
|
1518.865765
|
|
LMSP0505AG02
|
Ley-6(d18:1/18:0)
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(3)-HexNAc-Fuc(2)-Cer 36:1;O2
|
C74H134N2O31
|
1546.897065
|
|
LMSP0505AG03
|
Ley-6(d18:1/20:0)
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(3)-HexNAc-Fuc(2)-Cer 38:1;O2
|
C76H138N2O31
|
1574.928365
|
|
LMSP0505AG04
|
Ley-6(d18:1/22:0)
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(3)-HexNAc-Fuc(2)-Cer 40:1;O2
|
C78H142N2O31
|
1602.959665
|
|
LMSP0505AG05
|
Ley-6(d18:1/24:0)
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(3)-HexNAc-Fuc(2)-Cer 42:1;O2
|
C80H146N2O31
|
1630.990965
|
|
LMSP0505AG06
|
Ley-6(d18:1/26:0)
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(3)-HexNAc-Fuc(2)-Cer 44:1;O2
|
C82H150N2O31
|
1659.022265
|
|
LMSP0505AG07
|
Ley-6(d18:1/24:1(15Z))
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(3)-HexNAc-Fuc(2)-Cer 42:2;O2
|
C80H144N2O31
|
1628.975315
|
|
LMSP0505AG08
|
Ley-6(d18:1/26:1(17Z))
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(3)-HexNAc-Fuc(2)-Cer 44:2;O2
|
C82H148N2O31
|
1657.006615
|
|
LMSP0505AH01
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 34:1;O2
|
C80H143N3O37
|
1737.940054
|
|
LMSP0505AH02
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 36:1;O2
|
C82H147N3O37
|
1765.971354
|
|
LMSP0505AH03
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 38:1;O2
|
C84H151N3O37
|
1794.002654
|
|
LMSP0505AH04
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 40:1;O2
|
C86H155N3O37
|
1822.033954
|
|
LMSP0505AH05
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 42:1;O2
|
C88H159N3O37
|
1850.065254
|
|
LMSP0505AH06
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 44:1;O2
|
C90H163N3O37
|
1878.096554
|
|
LMSP0505AH07
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(4)-HexNAc(2)-Fuc-Cer 42:2;O2
|
C88H157N3O37
|
1848.049604
|
|
LMSP0505AH08
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(4)-HexNAc(2)-Fuc-Cer 44:2;O2
|
C90H161N3O37
|
1876.080904
|
|
LMSP0505AI01
|
type III H antigen(d18:1/16:0)
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 34:1;O2
|
C86H153N3O41
|
1883.997964
|
|
LMSP0505AI02
|
type III H antigen(d18:1/18:0)
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 36:1;O2
|
C88H157N3O41
|
1912.029264
|
|
LMSP0505AI03
|
type III H antigen(d18:1/20:0)
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 38:1;O2
|
C90H161N3O41
|
1940.060564
|
|
LMSP0505AI04
|
type III H antigen(d18:1/22:0)
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 40:1;O2
|
C92H165N3O41
|
1968.091864
|
|
LMSP0505AI05
|
type III H antigen(d18:1/24:0)
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 42:1;O2
|
C94H169N3O41
|
1996.123164
|
|
LMSP0505AI06
|
type III H antigen(d18:1/26:0)
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 44:1;O2
|
C96H173N3O41
|
2024.154464
|